PCSK9 Inhibitors in Primary Prevention: A New Paradigm for Family Physicians

The Evolving Role of High Efficacy, Anti-CD40 Therapeutics for Relapsing Multiple Sclerosis

Review of Biosimilar Therapeutics for Patients with Relapsing Multiple Sclerosis

Update on Clinical Data and Applications for Anti-CD20 Therapeutics to Treat Relapsing Multiple Sclerosis

What Every Family Medicine Physician Should Know About Hepatic Encephalopathy: Recognition, Differential Diagnosis, Diagnostic Testing, and Appropriate Referral

EHA2026: New Data on the Management of Anemia in Myelofibrosis